Tracking every rollback, reversal, and overreach — and the path back to the America we know.
The Trump administration appointed Rosario "Pete" Vasquez as the new chief of the U.S. Border Patrol, replacing Michael Banks who resigned in May 2026. The appointment escalates enforcement capacity within U.S. Customs and Border Protection during an administration marked by aggressive immigration restrictions. The leadership change signals continued prioritization of border enforcement and deportation operations.
President Trump's immigration restrictions are causing one of the sharpest declines in U.S. population growth in decades, with measurable economic consequences visible in employment figures. The policy-driven reversal is reducing labor force expansion and creating productivity drags expected to persist for years. Economists warn the cumulative economic damage from reduced immigration will have long-term negative effects on GDP growth and competitiveness.
The Trump administration narrowed protections for approximately 500,000 DACA (Deferred Action for Childhood Arrivals) recipients by slowing renewal processing, tightening deportation protections, and ramping up enforcement actions against program participants. The policy reverses Trump's previous public statements of sympathy toward Dreamers and exposes them to increased deportation risk and work authorization disruptions.
The Trump administration's cuts to U.S. and global health programs have compromised the federal government's ability to respond to hantavirus and other disease threats. Career scientists at the CDC have been fired or departed, reducing the agency's capacity to manage infectious disease outbreaks. Public health experts warn these cuts leave America unprepared for larger health crises.
The Trump administration has directed federal agencies to scale back and abandon ongoing discrimination cases and enforcement actions that date back decades. This systematic withdrawal removes legal accountability across employment, education, housing, and public accommodations. Millions of Americans lose federal protection against discrimination in hiring, education access, housing, and public services.
A federal judge in Massachusetts ordered the Trump administration to reinstall displays removed from National Parks sites that contained diversity, equity, inclusion (DEI) content and climate change information. The Trump administration had systematically removed these exhibits as part of a crackdown on DEI initiatives and climate science messaging. Park advocacy organizations successfully challenged the removals in federal court, resulting in a judicial mandate to restore the displays.
The Trump administration implemented a ban on abortion care and counseling services at the Department of Veterans Affairs (VA), affecting veteran patients with reproductive health needs. A veterans advocacy group sued on behalf of affected members, including pregnant veterans with chronic medical conditions. The ban restricts access to healthcare services previously available to eligible veterans.
The Trump EPA approved three new pesticides containing per- and polyfluoroalkyl substances (PFAS), molecules with carbon-fluorine bonds that persist indefinitely in the environment and bioaccumulate in human bodies. The agency disputed the 'forever chemicals' characterization despite international scientific consensus. The approval prioritizes agricultural chemical industry interests over public health and environmental protection.
The Trump administration began issuing $85 billion in tariff refunds to U.S. importers after the Supreme Court ruled in February 2026 that Trump had overstepped his authority in enacting sweeping tariffs. As of May 2026, $20 billion has been refunded with $65 billion more pending. The ruling and subsequent refunds represent a significant legal defeat for the administration's tariff agenda.
HHS Secretary Robert F. Kennedy Jr. extended legal protections through July 18 for manufacturers and distributors of the experimental antiviral drug favipiravir as a potential treatment for Andes hantavirus. Kennedy invoked a Public Readiness and Emergency Preparedness (PREP) Act declaration to shield drugmakers from liability. The action drew criticism from 'Make America Healthy Again' activists concerned about vaccine and pharmaceutical company immunity.